Showing 1 - 10 of 48
The economic theory of intellectual property rights is based on a rather narrow view of both competition and technological knowledge. We suggest some ways of enriching this framework with a more empirically grounded view of both and, by means of a simulation model, we analyze the impact of...
Persistent link: https://www.econbiz.de/10010328651
This note discusses the medical/therapeutical responses to the COVID-19 pandemic and their 'political economy' context. First, the very quick development of several vaccines highlights the richness of the basic knowledge waiting for therapeutical exploitation. Such knowledge has largely...
Persistent link: https://www.econbiz.de/10012651879
Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...
Persistent link: https://www.econbiz.de/10012692751
The economic theory of intellectual property rights is based on a rather narrow view of both competition and technological knowledge. We suggest some ways of enriching this framework with a more empirically grounded view of both and, by means of a simulation model, we analyze the impact of...
Persistent link: https://www.econbiz.de/10005292656
The economic theory of intellectual property rights is based on a rather narrow view of both competition and technological knowledge. We suggest some ways of enriching this framework with a more empirically grounded view of both and, by means of a simulation model, we analyze the impact of...
Persistent link: https://www.econbiz.de/10008732424
This note discusses the medical/therapeutical responses to the COVID-19 pandemic and their “political economy” context. First, the very quick development of several vaccines highlights the richness of the basic knowledge waiting for therapeutical exploitation. Such knowledge has largely...
Persistent link: https://www.econbiz.de/10012520259
Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...
Persistent link: https://www.econbiz.de/10012604733
The role of the patent system in the pharmaceutical sector is highly debated also due to its strong public health implications. In this paper we develop an evolutionary, agent-based model of the pharmaceutical industry to explore the impact of different configurations of the patent system upon...
Persistent link: https://www.econbiz.de/10012692762
The role of the patent system in the pharmaceutical sector is highly debated also due to its strong public health implications. In this paper we develop an evolutionary, agent-based model of the pharmaceutical industry to explore the impact of different configurations of the patent system upon...
Persistent link: https://www.econbiz.de/10012654995
This position paper outlines the characteristics of the trends at stake in affecting the twin transition in the European automotive industry, and the political economy of the actors behind such transition. We first describe the automation and digitalization processes in the automotive sector and...
Persistent link: https://www.econbiz.de/10014541716